A Randomized Phase II Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac).
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2012
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; AS03A
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Acronyms HIFLUVAC
- 10 Jun 2017 Biomarkers information updated
- 26 Sep 2012 Results published in AIDS.
- 21 Jan 2011 Actual end date (Dec 2010 ) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History